Esther Welkowsky
Technik-/Wissenschafts-/F&E-Leiter bei ELICIO THERAPEUTICS, INC.
Profil
Esther Welkowsky is currently the Vice President-Clinical Development at Elicio Therapeutics, Inc. (United States) and the Senior Vice President-Clinical Development at Elicio Therapeutics, Inc. She previously worked as the Executive Director-Clinical Operations at Allogene Therapeutics, Inc. from 2018 to 2020.
Prior to that, she was the Head-Clinical Operations at Atara Biotherapeutics, Inc. Ms. Welkowsky completed her undergraduate degree at the University of California, Santa Barbara.
Aktive Positionen von Esther Welkowsky
| Unternehmen | Position | Beginn |
|---|---|---|
| ELICIO THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | - |
Elicio Therapeutics, Inc. (Old)
 Elicio Therapeutics, Inc. (Old) BiotechnologyHealth Technology Elicio Therapeutics, Inc. engages in the development of vaccines for infectious disease and cancer. Its programs focus on a novel lipid nanocapsule platform technology for delivering vaccines in a form mimicking the structure of pathogens to elicit potent immunity in prophylactic and therapeutic settings. The company was founded by Satish Jindal and Darrell Irvine on August 10, 2011 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01.04.2020 |
Ehemalige bekannte Positionen von Esther Welkowsky
| Unternehmen | Position | Ende |
|---|---|---|
| ALLOGENE THERAPEUTICS, INC. | Corporate Officer/Principal | 01.02.2020 |
| ATARA BIOTHERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Esther Welkowsky
| University of California, Santa Barbara | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| ALLOGENE THERAPEUTICS, INC. | Health Technology |
| ATARA BIOTHERAPEUTICS, INC. | Health Technology |
| ELICIO THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Elicio Therapeutics, Inc. (Old)
Elicio Therapeutics, Inc. (Old) BiotechnologyHealth Technology Elicio Therapeutics, Inc. engages in the development of vaccines for infectious disease and cancer. Its programs focus on a novel lipid nanocapsule platform technology for delivering vaccines in a form mimicking the structure of pathogens to elicit potent immunity in prophylactic and therapeutic settings. The company was founded by Satish Jindal and Darrell Irvine on August 10, 2011 and is headquartered in Cambridge, MA. | Health Technology |
